With the popularization of lung cancer screening and the clinical application of computed tomography (CT), the number of detected pulmonary nodules has significantly increased, many of which are adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA), and invasive adenocarcinoma (IAC). After surgical resection, the 5-year survival rate of AIS and MIA is close to 100%, and the recurrence rate is 0%, while IAC does not have such good survival benefits….
cd274
Cyclin in Tumor: Cdk5 Disruption Promotes Antitumor Immunity
R. Dixon Dorand et al. have found that Cdk5 disruption can help outcome tumor medulloblastoma. They published their research results in Science Magazine (Science 22 Jul 2016: Vol. 353, Issue 6297, pp. 399-403 DOI: 10.1126/science.aae0477), and we share this wonderful article here. By the way, Creative Biomart provides kinds of molecular tools to promote your research about tumor therapy. [table caption=”Related Products” width=”800″ colwidth=”80|180|180″ colalign=”left|left|center|center|center”] Cat. #,Product name,Source(Host),Species,Conjugate CDK5-3204M,Recombinant Mouse CDK5 Protein,Mammalian…